1)Hewitt RE, Lissina A, Green AE et al:The bisphosphonate acute phase response:rapid and cupious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins. Clin Exp Immunol 139:101-111, 2005
2)西岡木綿子・中尾新太郎・川野庸一・他:ゾレドロン酸水和物静注後に生じた急性前部ぶどう膜炎の1例.あたらしい眼科30:273-275,2013
3)Fraunfelder FW, Fraunfelder FT:Bisphosphonates and ocular inflammation. N Eng J Med 348:1187-1188, 2003
4)Patel DV, Bolland M, Nisa Z et al:Incidence of ocular side effects with intravenous zoledronate:Secondary analysis of a randomized controlled trial. Osteoporos Int 26:499-503, 2015
5)Patel DV, Horne A, House M et al:The incidence of acute anterior uveitis after intravenous zoledronate. Ophthalmology 120:773-776, 2013
6)Sharma NS, Ooi JL, Masselos K et al:Zoledronic acid infusion and orbital inflammatory disease. N Eng J Med 359:1410-1411, 2008
7)Phillips PM, Newman SA:Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma. Arch Ophthalmol 126:137-139, 2008
8)Tian Y, Wang R, Liu L et al:Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate:a case report. BMC Musculoskelet Disord 17:72, 2016
9)Mantovani A, Resta A, Herbort CP et al:Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease:a case report of acute myopization with granulomatous uveitis. Int Ophthalmol 27:105-115, 2007